First Trust NYSE Arca Biotechnology Index Fund
194 hedge funds and large institutions have $1.45B invested in First Trust NYSE Arca Biotechnology Index Fund in 2018 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 62 increasing their positions, 57 reducing their positions, and 41 closing their positions.
140% more call options, than puts
Call options by funds: $1.65M | Put options by funds: $687K
15% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 41
3% more funds holding
Funds holding: 189 → 194 (+5)
9% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 57
33.18% less ownership
Funds ownership: 94.23% → 61.04% (-33%)
36% less capital invested
Capital invested by funds: $2.25B → $1.45B (-$801M)
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$21.5M |
| 2 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$12.9M |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
+$4.62M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.24M |
| 5 |
BFEC
Benjamin F. Edwards & Company
St. Louis,
Missouri
|
+$3.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
Churchill Management
Los Angeles,
California
|
-$346M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
-$51.1M |
| 3 |
NA
Navellier & Associates
Reno,
Nevada
|
-$27M |
| 4 |
GA
Gateway Advisory
Westfield,
New Jersey
|
-$8.31M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$7.79M |
FBT Hedge Fund Activity: Q4 2018 in Review
194 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q4 2018, worth a combined $1.45B — down 36% from $2.25B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new FBT positions and 41 closed out — a net gain of 6 holders — while 62 added to existing stakes and 57 trimmed.
The largest buyer was Carson Wealth (CWM LLC), adding an estimated $21.5M. The largest seller was Churchill Management, exiting entirely with an estimated $346M sold.
- 194 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q4 2018, up from 189 in Q3 2018.
- Funds reported $1.45B of First Trust NYSE Arca Biotechnology Index Fund stock for Q4 2018, down 36% quarter-over-quarter.
- 47 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q4 2018 and 41 closed out, a net change of +6 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q4 2018 was Carson Wealth (CWM LLC), an estimated $21.5M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q4 2018 was Churchill Management, an estimated $346M sold.
Based on aggregated 13F filings for Q4 2018.